Latest Manufacturing News

First Graphene has locked in a 12-month exclusive global license to develop and sell graphene-enhanced carbon paste, a breakthrough material already boosting solar cell efficiency and cutting costs.

HyTerra Limited has partnered with GeoKiln Energy Innovation to pioneer a groundbreaking test of engineered geologic hydrogen production, aiming to accelerate commercialization in this emerging energy sector.

Fisher & Paykel Healthcare reported a robust 14% revenue increase and a 39% jump in net profit for the first half of fiscal 2026, driven by strong clinical adoption and product innovation.

Pure Foods Tasmania has acquired premium ice cream brand Elato, integrating it with its Cashew Creamery to form a new Ice Cream Division led by Elato’s founder. This move broadens PFT’s product range and leverages existing manufacturing capabilities.

Aguia Resources has appointed Tim Hosking as its new CEO, signaling a strategic push towards phosphate production in Brazil set for early 2026, while addressing operational challenges at its Colombian gold project.

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

VRX Silica Limited has raised $2.1 million through a share placement to fund critical pre-construction activities at its Arrowsmith North Silica Sand Project, aiming to strengthen its position in high-quality silica sand markets.

Element 25 Limited is making significant strides in expanding its Butcherbird Manganese Mine, securing $60 million in funding and advancing critical engineering and contract milestones to boost manganese concentrate production to 1.1 million tonnes per annum.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Zeotech Limited’s AusPozz™ has been independently validated by BG&E as a high-performance, low-carbon supplementary cementitious material, showing remarkable strength gains and durability benefits in concrete applications.